Saturday 17 October 2026
Export IVPR’s income statement to Excel — free account
Inspire Veterinary Partners, Inc.
IVPR Consumer Cyclical Personal Services
Inspire Veterinary Partners, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $16.6 million, roughly unchanged from fiscal 2023. In the quarter to September 2025, revenue grew 6.60%, EPS grew 51.7% and free cash flow grew 79.1%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow IVPR
| Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|
Piotroski F-Score |
— | — | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | 96.66 | (2.68) |
P/S ratio |
0.00 | 231.96 | 1.60 |
Altman Z″-Score (non-manufacturers) |
(4.18) | (7.30) | (10.79) |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (4.72) | (4.20) |
P/Operating CF |
(6,699.59) | (5,124.60) | (39.24) |
P/B ratio |
0.00 | 0.00 | 17.02 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 232.76 | 2.08 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(423.42) | (1,015.85) | (3.45) |
EV/FCF |
(391.91) | (923.14) | (2.96) |
Quick Ratio |
0.13 | 0.05 | 0.07 |
Current Ratio |
0.24 | 0.18 | 0.25 |
Net Debt/EBITDA |
(8.36) | (2.79) | (1.57) |
Debt/Assets |
86.23% | 61.88% | 42.04% |
Debt/Equity |
(3.39) | (17.10) | 5.44 |
Asset Turnover |
0.00 | 0.79 | 0.79 |
Operating CF/Net income |
0.54 | 0.25 | 0.69 |
Capex/Depreciation |
(0.12) | (0.16) | (0.06) |
Interest Coverage |
(2.47) | (2.83) | (2.91) |
| 0.00% | 508.60% | (3,744.37%) | |
| 0.00% | (71.77%) | (69.00%) | |
ROIC |
(18.59%) | (35.83%) | (59.21%) |
Return on Tangible Assets |
(270.57%) | (876.13%) | (7,011.18%) |
Average Days of Receivables |
17.15 | 4.66 | 0.90 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
55.59% | 56.83% | 68.84% |
Intangible Assets out of Total Assets |
0.51 | 0.49 | 0.48 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.14% |
Graham Net Nets |
(0.02) | (0.01) | (0.62) |
Graham Number |
0.00 | 82.60 | 0.00 |
Earnings Yield |
(41.29%) | (184.70%) | (68.68%) |
Free Cash Flow Yield |
(0.26%) | (0.11%) | (43.91%) |
Revenue per Share |
4,683.24 | 3.87 | 2.99 |
Operating CF per Share |
(1,265.86) | (0.89) | (1.80) |
Capex per Share |
(84.19) | (0.09) | (0.04) |
Free Cash Flow per Share |
(1,350.05) | (0.98) | (1.85) |
Cash per Share |
211.57 | 0.04 | 0.09 |
Shareholders Equity per Share |
(2,445.48) | (0.18) | 0.28 |
Interest Debt per Share |
0.01 | 0.00 | 0.00 |
Book value per Share |
(2,445.48) | (0.18) | 0.28 |
Free Cash Flow |
(2.84) | (4.20) | (10.24) |
Working Capital |
(5.51) | (6.23) | (6.18) |
Capital Expenditures |
(0.18) | (0.38) | (0.24) |
Net Current Asset Value |
(23.58) | (21.23) | (16.61) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.20 | 0.30 | 0.62 |
Cash ROIC |
(22.30%) | (32.66%) | (96.86%) |
Accounts Receivable Turnover |
0.00 | 49.42 | 130.85 |
Accounts Payable Turnover |
0.00 | 6.21 | 5.13 |
Inventory Turnover |
0.00 | 22.75 | 24.44 |
Average Days of Payables |
51.02 | 89.20 | 54.33 |
Days of Inventory on Hand |
29.14 | 15.90 | 14.18 |
Average Receivables |
— | 0.34 | 0.13 |
Average Payables |
— | 2.11 | 2.59 |
Average Inventory |
— | 0.58 | 0.54 |
Average Assets |
— | 20.99 | 20.99 |
Average Common Equity |
— | (2.96) | 0.39 |
Columns are period end dates